John Couling - Nov 15, 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role: SVP, Entertainment
Signature: /s/ Daniel Rodriguez, Attorney-in-Fact for John Couling
Stock symbol: DLB
Transactions as of: Nov 15, 2023
Transactions value $: -$6,998
Form type: 4
Date filed: 11/17/2023, 04:10 PM
Previous filing: May 16, 2023
Next filing: Dec 19, 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DLB	Class A Common Stock	Sale	-$7K	-79	-0.08%	$88.58	96.4K	Nov 15, 2023	Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held following the reported transaction include 43,636 restricted stock units, which are subject to forfeiture until they vest.
F2	Shares include (1) 87 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021, (2) 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022, and (3) 79 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2023. The shares acquired on November 15, 2021 and November 15, 2022 were not included in share totals reported previously due to administrative error.

Content

Shares held following the reported transaction include 43,636 restricted stock units, which are subject to forfeiture until they vest.

Shares include (1) 87 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2021, (2) 38 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2022, and (3) 79 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2023. The shares acquired on November 15, 2021 and November 15, 2022 were not included in share totals reported previously due to administrative error.

Remarks:

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 17, 2022, as amended February 6, 2023, which was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) in effect at the time of adoption.